Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BridgeBio Pharma (BBIO) Minority Interest: 2019-2025

Historic Minority Interest for BridgeBio Pharma (BBIO) over the last 7 years, with Sep 2025 value amounting to $10.3 million.

  • BridgeBio Pharma's Minority Interest fell 5.21% to $10.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.3 million, marking a year-over-year decrease of 5.21%. This contributed to the annual value of $10.2 million for FY2024, which is 9.73% down from last year.
  • As of Q3 2025, BridgeBio Pharma's Minority Interest stood at $10.3 million, which was up 4.37% from $9.9 million recorded in Q2 2025.
  • In the past 5 years, BridgeBio Pharma's Minority Interest ranged from a high of $12.4 million in Q3 2023 and a low of $336,000 during Q1 2022.
  • For the 3-year period, BridgeBio Pharma's Minority Interest averaged around $11.1 million, with its median value being $11.1 million (2024).
  • Its Minority Interest has fluctuated over the past 5 years, first slumped by 92.94% in 2021, then skyrocketed by 3,547.62% in 2023.
  • BridgeBio Pharma's Minority Interest (Quarterly) stood at $3.4 million in 2021, then soared by 230.66% to $11.3 million in 2022, then decreased by 0.34% to $11.2 million in 2023, then decreased by 9.73% to $10.2 million in 2024, then fell by 5.21% to $10.3 million in 2025.
  • Its Minority Interest stands at $10.3 million for Q3 2025, versus $9.9 million for Q2 2025 and $10.0 million for Q1 2025.